Enrique Ruiz, PA-C

Enrique Ruiz practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Enrique Ruiz's NPI, 1497881692, was assigned on February 24, 2007. Enrique Ruiz holds Florida license PA9104245.

Enrique Ruiz's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Enrique Ruiz's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Enrique Ruiz is also affiliated with Cape Coral Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Enrique Ruiz to 6 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Enrique Ruiz practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Enrique Ruiz's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Enrique Ruiz is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Enrique Ruiz's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists acute sinusitis, acute skin infection, ankle or foot injury, benign or precancerous skin growths, bronchitis, bursitis, conjunctivitis and contact dermatitis among the conditions Enrique Ruiz treats.

CMS data shows 2,070 Medicare services from Enrique Ruiz across 12 procedure codes in 2024, for 452 Medicare patients. Medicare paid $101,673 for them. Every service was in an office.

CMS counts 452 Medicare patients who saw Enrique Ruiz in 2024. The largest group is 85 and over, with 255 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Enrique Ruiz's median patient age at 66, with 47% women.

In 2024, Enrique Ruiz wrote 230 Medicare Part D claims for 174 patients. 99% of them were for generic drugs. CMS names the drug for 134 of them, across 6 drugs with 11 or more claims each, at $1,555 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Enrique Ruiz for performance year 2024, reported as part of a group. Enrique Ruiz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Enrique Ruiz from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $218.